Key Record Dates Identifier: NCT04609800
Brief Title: Study on the Utilization of Cabozantinib in Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) in 2nd Line Treatment Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy Under Real-real Life Clinical Setting in France. (CAROLINE)

First Submitted : October 7, 2020
First Submitted that Met QC Criteria : October 29, 2020
First Posted : October 30, 2020

Last Update Submitted that Met QC Criteria : December 17, 2020
Last Update Posted : December 21, 2020